Free Trial

Centene (CNC) Stock Price, News & Analysis

Centene logo
$30.84 -0.60 (-1.89%)
As of 11:30 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Centene Stock (NYSE:CNC)

Key Stats

Today's Range
$30.84
$31.62
50-Day Range
$31.42
$62.82
52-Week Range
$30.77
$80.59
Volume
4.46 million shs
Average Volume
5.77 million shs
Market Capitalization
$15.35 billion
P/E Ratio
4.60
Dividend Yield
N/A
Price Target
$64.75
Consensus Rating
Hold

Company Overview

Centene Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
100th Percentile Overall Score

CNC MarketRank™: 

Centene scored higher than 100% of companies evaluated by MarketBeat, and ranked 16th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Centene has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 6 buy ratings, 12 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Centene has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Centene's stock forecast and price target.
  • Earnings Growth

    Earnings for Centene are expected to grow by 7.43% in the coming year, from $6.86 to $7.37 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Centene is 4.60, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.20.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Centene is 4.60, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.22.

  • Price to Earnings Growth Ratio

    Centene has a PEG Ratio of 0.50. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Centene has a P/B Ratio of 0.59. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Centene's valuation and earnings.
  • Percentage of Shares Shorted

    2.01% of the float of Centene has been sold short.
  • Short Interest Ratio / Days to Cover

    Centene has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Centene has recently increased by 6.02%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Centene does not currently pay a dividend.

  • Dividend Growth

    Centene does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.01% of the float of Centene has been sold short.
  • Short Interest Ratio / Days to Cover

    Centene has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Centene has recently increased by 6.02%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Centene has a news sentiment score of 0.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.01 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 67 news articles for Centene this week, compared to 22 articles on an average week.
  • Search Interest

    93 people have searched for CNC on MarketBeat in the last 30 days. This is an increase of 365% compared to the previous 30 days.
  • MarketBeat Follows

    18 people have added Centene to their MarketBeat watchlist in the last 30 days. This is an increase of 350% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Centene insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.36% of the stock of Centene is held by insiders.

  • Percentage Held by Institutions

    93.63% of the stock of Centene is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Centene's insider trading history.
Receive CNC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Centene and its competitors with MarketBeat's FREE daily newsletter.

CNC Stock News Headlines

Financial markets news icon
MarketBeat Week in Review – 07/07 - 07/11 (CNC)
NVDA stock hit a $4 trillion market cap, but tariff concerns brought back the bears; next week brings a slew of economic data and the start of earnings season...
September 4, 2024, Paraguay. In this photo illustration, the Centene Corporation logo is displayed on a smartphone screen — Stock Editorial Photography
Why Centene Stock Dropped 40% — And Whether It's a Buy Now
Centene just crashed. But, price target updates signal the selloff is overdone, with 50% upside in play. However, the "Big Beautiful Bill" is another curveball.
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
See More Headlines

CNC Stock Analysis - Frequently Asked Questions

Centene's stock was trading at $60.58 at the beginning of 2025. Since then, CNC shares have decreased by 49.1% and is now trading at $30.8450.

Centene Corporation (NYSE:CNC) posted its quarterly earnings results on Friday, April, 25th. The company reported $2.90 EPS for the quarter, beating the consensus estimate of $2.52 by $0.38. The company's revenue for the quarter was up 15.4% on a year-over-year basis.
Read the conference call transcript
.

Shares of Centene split on the morning of Wednesday, February 6th 2019.The 2-1 split was announced on Tuesday, February 5th 2019. The newly created shares were distributed to shareholders after the market closes on Tuesday, February 5th 2019. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Centene subsidiaries include these companies: Magellan Health Inc, PANTHERx Rare Pharmacy, Apixio, WellCare Health Plans, Community Medical Group, MHM, Fidelis Care, and more.

Centene's top institutional shareholders include Assenagon Asset Management S.A. (0.37%), Swedbank AB (0.31%), Wedge Capital Management L L P NC (0.11%) and Allen Mooney & Barnes Investment Advisors LLC (0.05%). Insiders that own company stock include Sarah London, Andrew Lynn Asher, Kenneth J Fasola, Shannon Bagley, Christopher J Coughlin, Theodore R Samuels II, Thomas Greco, Lori Jean Robinson and H James Dallas.
View institutional ownership trends
.

Shares of CNC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Centene investors own include Humana (HUM), NVIDIA (NVDA), Meta Platforms (META), American Water Works (AWK), Salesforce (CRM), Advanced Micro Devices (AMD) and Verizon Communications (VZ).

Company Calendar

Last Earnings
4/25/2025
Today
7/14/2025
Next Earnings (Estimated)
7/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - HMO
Sub-Industry
Managed Health Care
Current Symbol
NYSE:CNC
CIK
1071739
Employees
60,500
Year Founded
1984

Price Target and Rating

High Price Target
$89.00
Low Price Target
$33.00
Potential Upside/Downside
+106.1%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
18 Analysts

Profitability

EPS (Trailing Twelve Months)
$6.71
Trailing P/E Ratio
4.68
Forward P/E Ratio
4.58
P/E Growth
0.5
Net Income
$3.31 billion
Net Margins
2.04%
Pretax Margin
2.68%
Return on Equity
14.56%
Return on Assets
4.75%

Debt

Debt-to-Equity Ratio
0.65
Current Ratio
1.11
Quick Ratio
1.11

Sales & Book Value

Annual Sales
$163.07 billion
Price / Sales
0.10
Cash Flow
$9.88 per share
Price / Cash Flow
3.18
Book Value
$52.49 per share
Price / Book
0.60

Miscellaneous

Outstanding Shares
497,600,000
Free Float
495,812,000
Market Cap
$15.63 billion
Optionable
Optionable
Beta
0.44

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NYSE:CNC) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners